Verona, NJ, United States of America

Catherine D Strader


Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1994-2002

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine D. Strader

Introduction

Catherine D. Strader is a prominent inventor based in Verona, NJ (US), known for her significant contributions to the field of biochemistry and pharmacology. With a total of 12 patents to her name, she has made remarkable advancements in understanding and manipulating human receptors, which are crucial for developing new therapeutic drugs.

Latest Patents

One of her latest patents is titled "Cloned and expressed human bradykinin BK-2 receptor." This invention involves a cloned human BK-2 bradykinin receptor derived from a human lung fibroblast cell line. The cDNA clone encodes a novel 364 amino acid protein that exhibits the characteristics of a seven transmembrane domain G-protein coupled receptor. This invention is instrumental in expressing a BK-2 bradykinin receptor in host mammalian cells, facilitating the screening for pharmaceutical antagonists or agonists that interact with the BK-2 bradykinin receptor protein. Another significant patent is the "Method for measuring human neurokinin-3 receptor ligand binding." This patent discloses a recombinant human neurokinin-3 receptor, prepared using polymerase chain reaction techniques. It includes the complete sequence of human NK3R complementary DNA and describes expression systems, such as a CHO (Chinese hamster ovarian cell line) stable expression system. The human NK3R can be utilized in assays to identify and evaluate entities that bind to the neurokinin-3 receptor.

Career Highlights

Catherine has had a distinguished career, working with notable organizations such as Merck & Company, Inc. and the University of Pennsylvania. Her work in these institutions has allowed her to collaborate with leading scientists and contribute to groundbreaking research in receptor biology.

Collaborations

Throughout her career, Catherine has collaborated with esteemed colleagues, including Tung M. Fong and Margaret A. Cascieri. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Catherine D. Strader's innovative work and numerous patents have significantly impacted the understanding of human receptors and their applications in drug development. Her contributions continue to inspire future research in pharmacology and biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…